Instalab
logoInstalab

Citrate

24 Hour Urine Test
Your earliest signal of kidney stone risk, often missed when standard blood tests look normal.

Should you take a Citrate test?

This test is most useful if any of these apply to you.

Had a Kidney Stone
If you have passed a stone or had one removed, this test reveals which urine chemistry factors are working against you and what you can change.
Already Managing Kidney Issues
For people with chronic kidney disease, low citrate signals acid retention that standard blood tests can miss, opening the door to early treatment.
Taking Topiramate or Other Stone-Triggering Meds
Some medications quietly drop urine citrate and raise stone risk; this test shows whether your treatment is silently working against your kidneys.
Family History of Kidney Stones
If stones run in your family, knowing your citrate level gives you a head start on prevention before your first painful episode.

About Citrate

If you have ever had a kidney stone, or you are watching someone in your family go through them, you already know the pain is unforgettable. The 24-hour urine citrate test is one of the most useful numbers for understanding why stones keep forming and what you can do to stop them. It captures something a routine blood panel cannot: how well your urine is protected against calcium crystals clumping together in the first place.

Citrate binds calcium in the urine and keeps it from latching onto oxalate or phosphate to form stones. When your urine citrate runs low, the chemistry tips toward stone formation. When it runs high, your urine is more protective. Knowing your number gives you a target you can actually move.

What This Test Actually Measures

Citrate is a small molecule produced by the citric acid cycle, the chemical loop your cells use to turn food into energy. Your kidneys filter citrate, reabsorb most of it, and release the rest into your urine. The amount that ends up in your urine over a full day reflects two things at once: how much your cells produce and how aggressively your kidneys hold onto it.

This test collects every drop of urine you produce in 24 hours and measures the total citrate excreted. Because urinary citrate rises and falls throughout the day, with the lowest levels in the early morning hours, a full-day collection captures your true average rather than a single moment in time.

Why Low Citrate Matters for Kidney Stones

Low urinary citrate, called hypocitraturia, is one of the most consistent risk factors for calcium stone formation. In a study of 6,217 adults, higher urinary citrate was associated with lower kidney stone risk alongside other protective factors like higher urine volume and magnesium. A separate study of 430 adults found that stone formers excreted significantly less citrate over 24 hours than people without stones.

The biology is straightforward. Citrate grabs onto calcium in the urine and keeps it tied up in solution. Without enough citrate, calcium is free to bond with oxalate or phosphate and start building crystals. Hypocitraturia is described as one of the most common, treatable causes of stones, contributing to roughly half of cases in stone formers.

Chronic Kidney Disease and Acid Retention

Citrate excretion drops when your body is holding onto extra acid, even before standard blood tests would call it metabolic acidosis. In a study of 66 people with chronic kidney disease (CKD), urine citrate was lower in those with acid retention even when serum bicarbonate looked normal, and citrate rose when participants ate more fruits and vegetables or took alkali.

In a larger study of 1,805 people, the urinary citrate-to-creatinine ratio was a more sensitive marker for acid-base status and alkali therapy response than serum bicarbonate. Among 2,057 stone patients, those with higher CKD stages showed lower urinary citrate, a shift that pushes urine chemistry toward stone formation just when the kidneys can least afford it.

Bone Health Connection

Severe hypocitraturia may also signal bone trouble. In a study of 9,025 patients with kidney stone disease, urinary citrate below 200 mg per day was modestly associated with higher osteoporosis or fracture risk. The proposed link is chronic low-grade acid load, which can drive both low citrate and accelerated bone breakdown. The bone signal is weaker than the stone signal, but it suggests that hypocitraturia is rarely just about kidneys.

Diabetic Kidney Disease

In a study of 2,670 people with type 1 diabetes, higher urinary citrate (per creatinine) was associated with a lower risk of diabetic nephropathy progression, with a hazard ratio of 0.84 per standard deviation. In plain language, people with more citrate in their urine were about 16% less likely to see their kidney disease progress for each one-unit step up in citrate. The signal points to citrate as a marker of kidney health, not just stone risk.

Hypertension and Metabolic Conditions

In a study of 3,024 adults, lower 24-hour urinary citrate was independently associated with prevalent high blood pressure. Among 2,561 adults, lower citrate also tracked with higher BMI, gout, and thiazide diuretic use, while higher citrate tracked with higher potassium intake. The pattern suggests citrate excretion is sensitive to broader metabolic health, not just stone biology.

Reference Ranges

There is no single universally accepted threshold, and citrate excretion varies by sex, age, and body size. The values below come from clinical practice in stone prevention and reflect commonly used cutpoints rather than strict cutoffs from one specific population. Compare your results within the same lab over time for the most meaningful trend.

Tier24-Hour Urine CitrateWhat It Suggests
Severe hypocitraturiaBelow 200 mg/dayModestly higher risk of bone disease in stone formers; strong stone risk
HypocitraturiaBelow 320 mg/dayBelow the threshold often used to define low citrate; stone protection reduced
AdequateRoughly 320 to 640 mg/dayWithin typical ranges for stone formers receiving treatment
Higher protective rangeAbove 640 mg/dayAssociated with lower stone risk; commonly seen with alkali therapy or fruit and vegetable intake

What this means for you: a single number in the hypocitraturic range deserves a follow-up collection rather than an immediate panic. Citrate varies day to day with diet and activity, so two collections under typical conditions are more meaningful than one.

Tracking Your Trend

A single 24-hour citrate measurement is a snapshot, not a verdict. Citrate fluctuates with diet, hydration, sleep, and acid-base status, and there is meaningful day-to-day variation. The most useful information comes from watching the trend over time, especially after you change your diet or start a treatment.

A reasonable approach: get a baseline collection, repeat it a second time before making changes if the first looks abnormal, then retest 8 to 12 weeks after starting any intervention. After that, an annual recheck makes sense if you have stones, CKD, or are on treatments like potassium citrate. People with active stone disease often benefit from more frequent monitoring tied to symptom episodes.

When Results Can Be Misleading

A few things can make a single citrate reading look worse or better than it actually is.

  • Incomplete collection: missing even a few hours of urine throws off the total. Most labs check creatinine to confirm your collection was complete.
  • Recent diet swings: a high-protein meal pattern in the days before the test can lower citrate, while a fruit-heavy or vegetable-heavy stretch can raise it. Eat your typical diet during the collection.
  • Topiramate (a migraine and seizure medication): in 34 patients starting topiramate, urinary citrate fell sharply by 30 days, and 62% to 86% developed hypocitraturia within 60 days. This is a real drug effect on citrate, but it does not mean you have a primary stone-forming problem.
  • Synthetic PTH 1-34 (for hypoparathyroidism): in 31 patients tracked up to 5 years, urinary citrate dropped substantially, raising the calcium-to-citrate ratio.

What an Abnormal Result Should Make You Do

If your citrate comes back low, the next step is not to panic but to investigate. A full 24-hour stone risk panel, including urine calcium, oxalate, uric acid, sodium, potassium, magnesium, and pH, gives the context you need. Pair this with a serum chemistry panel checking bicarbonate, potassium, and creatinine to look for acid retention or kidney function decline.

If you have a history of kidney stones, recurrent stones, or CKD, a urologist or nephrologist with stone-prevention experience can help interpret the full picture and guide treatment. Hypocitraturia rarely travels alone, and the pattern of abnormalities matters as much as any single number.

What Moves This Biomarker

Evidence-backed interventions that affect your Citrate level

Increase
Take potassium citrate
Potassium citrate is the standard medical treatment for low urine citrate. In 34 patients with topiramate-induced hypocitraturia, alkali therapy raised urinary citrate from about 198 to 408 mg/day, and the share with hypocitraturia fell from 85% to 40%, especially at doses of 90 mEq or higher. Long-term observational data in 503 stone formers and additional cohorts link adherence to potassium citrate with fewer recurrent stone events.
MedicationStrong Evidence
Decrease
Take topiramate (a migraine and seizure medication)
In 34 patients starting topiramate, urinary citrate dropped significantly by 30 days, and 62% to 86% developed hypocitraturia (citrate below 320 mg/day) within 60 days. Topiramate causes a mild metabolic acidosis that the kidneys compensate for by reabsorbing more citrate, leaving less in the urine. This is an unwanted side effect that meaningfully raises stone risk. If you take topiramate and form stones, alkali therapy can offset the drop.
MedicationStrong Evidence
Decrease
Take synthetic human parathyroid hormone 1-34 (PTH 1-34, used for hypoparathyroidism)
In 31 patients followed up to 5 years, subcutaneous PTH 1-34 caused a marked drop in urinary citrate. Citrate fell more than calcium, raising the calcium-to-citrate ratio and increasing the risk of calcium deposits in the kidneys and kidney stones. This drug-induced hypocitraturia is described as an unwanted side effect, not a benign lab change.
MedicationStrong Evidence
Increase
Eat more fruits and vegetables
Fruit and vegetable intake delivers an alkali load that raises urinary citrate. In a meta-analysis of non-pharmacological interventions, commercial fruit juices and dietary alkali sources increased urinary citrate. In CKD studies, base-producing diets raised citrate alongside reductions in acid retention. The shift moves your urine chemistry toward stone protection.
DietModerate Evidence
Decrease
Eat a high animal protein diet
In an observational study of 2,561 adults, higher non-dairy animal protein intake was associated with lower urinary citrate excretion. The mechanism is acid load: animal protein produces sulfuric acid during metabolism, which the kidneys offset partly by holding onto more citrate, leaving less in the urine. The shift increases your stone risk.
DietModerate Evidence
Increase
Take sodium bicarbonate (alkali therapy)
In a randomized trial of 14 patients with and without CKD, sodium bicarbonate reduced net acid excretion and increased urine pH, supporting the same acid-base shift that drives citrate higher. Other CKD studies show bicarbonate raises urine citrate as part of correcting acid retention. This is most useful for people with CKD or persistent hypocitraturia.
SupplementModerate Evidence
Increase
Take SGLT2 inhibitors (a class of diabetes medication)
In a cross-sectional study of 1,306 diabetic stone formers, SGLT2 inhibitor use was associated with higher mean urinary citrate (838 vs 636 mg/day) and higher urine volume compared with matched controls. The effect appears to be a beneficial side benefit for stone risk, though longitudinal within-person changes were not statistically significant.
MedicationModerate Evidence

Frequently Asked Questions

References

20 studies
  1. Ferraro PM, Taylor E, Curhan GAmerican Journal of Kidney Diseases2024
  2. Welshman SG, Mcgeown MBritish Journal of Urology1976
  3. Robinson M, Leitão V, Haleblian GE, Scales C, Chandrashekar a, Pierre S, Preminger GJournal of Urology2009
  4. Crivelli JJ, Oerline M, Maalouf N, Hsi RS, Krampe N, Smith KB, Best SL, Denton BT, Shahinian V, Hollingsworth JMKidney3602026
  5. Schaub JA, Oerline M, Crivelli J, Maalouf N, Best SL, Asplin JR, Hollingsworth JM, Shahinian V, Hsi RSKidney3602025